Search

everythinglearnresearchcommunity

for

Search:↓

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Anti-Ku-positive patients often have muscle weakness and autophagy plays a key role in their condition.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Targeted immune modulation can help achieve stable remission in alopecia areata.

The nodule was a benign cutaneous lymphadenoma, not cancer, and was successfully removed.

Alopecia areata may be caused by the immune system attacking hair follicles.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Interface dermatitis is the most common skin change in drug-induced hypersensitivity syndrome.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Graft-versus-host disease occurs when donor immune cells attack the recipient's body, causing skin, gut, and liver damage.

Stromal cells in melanoma promote tumor growth and spread.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Enhancing immune response can improve cancer treatment effectiveness.

Keloid scars are aggressive, excessive skin scars with unique features and complex diagnosis.

Common gene patterns may cause skin autoimmune diseases.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.